Measurement and removal of adherent endotoxin from titanium particles and implant surfaces

Journal of Orthopaedic Research

Volumn 17, Issue 6, 1999, Pages 803-809

  Ragab, Ashraf A ^a   Van De Motter, Renee ^a   Lavish, Sandra A ^a   Goldberg, Victor M ^a   Ninomiya, James T ^d   Carlin, Cathleen R ^b   Greenfield, Edward M ^a,b,c  

^a Departments of Orthopaedics   (United States)

^b Departments of Physiology and Biophysics   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRIFUGATION; TITANIUM; TITANIUM ALLOYS; WEAR OF MATERIALS;

ENDOTOXIN;

IMPLANTS (SURGICAL);

ENDOTOXIN; TITANIUM;

ARTICLE; CENTRIFUGATION; CYTOKINE PRODUCTION; ENDOPROSTHESIS LOOSENING; IMPLANT; MEASUREMENT; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SUPERNATANT; SURFACE PROPERTY;

EID: 0033378291     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100170603     Document Type: Article

References (55)

1. 1 Abu‐Amer Y, Ross FP, Edwards J, Teitelbaum SL: Lipopoly‐saccharide‐stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor. J Clin Invest 100: 1557–1565, 1997
2. 2 Al‐Saffar N, Khwaja HA, Kadoya Y, Revell PA: Assessment of the role of GM‐CSF in the cellular transformation and the development of erosive lesions around orthopaedic implants. Am J Clin Pathol 105: 628–639, 1996
3. 3 Amano S, Kawakami K, Iwahashi H, Kitano S, Hanazawa S: Functional role of endogenous CD14 in lipopolysaccharide‐stimulated bone resorption. J Cell Physiol 173: 301–309, 1997
4. 4 Bi Y, Ragab AA, Goldberg VM, Greenfield EM: Titanium wear particles stimulate osteoclast differentiation in vitro. Trans Orthop Res Soc 23: 372, 1998
5. 5 Bi Y, Van de motter RR, Ragab AA, Goldberg VM, Greenfield EM: The role of adherent endotoxin in stimulation of osteoclast differentiation by orthopaedic wear particles. Trans Orthop Res Soc 23: 5, 1999
6. 6 Blaine TA, Rosier RN, Puzas JE, Looney RJ, Reynolds PR, Reynolds SD, O'Keefe RJ: Increased levels of tumor necrosis factor‐α and interleukin‐6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg [Am] 78: 1181–1192, 1996
7. 7 Blaine TA, Pollice PF, Rosier RN, Reynolds PR, Puzas JE, O'Keefe RJ: Modulation of the production of cytokines in titanium‐stimulated human peripheral blood monocytes by pharmacological agents: the role of cAMP‐mediated signaling mechanisms. J Bone Joint Surg [Am] 79: 1519–1528, 1997
8. 8 Cardona MA, Simmons RL, Kaplan SS: TNF and IL‐1 generation by human monocytes in response to biomaterials. J Biomed Mater Res 26: 851–859, 1992
9. 9 Chiba J. Doyle JS, Noguchi K: Biochemical and morphological analyses of activated human macrophages and fibroblasts by particulate materials. Trans Orthop Res Soc 17: 343, 1992
10. 10 Cho DR, Hong CY, Baran GR, Goldring SR: Adsorbed endotoxin mediates differential effects on particle‐induced stimulation of cytokine and chemokine release. Trans Orthop Res Soc 24: 6, 1999
11. 11 Chow CW, Grinstein S, Rotstein OD: Signaling events in monocytes and macrophages. New Horiz 3: 342–351, 1995
12. 12 Daniels AU, Barnes FH, Charlebois SJ, Smith RA: Macrophage cytokine response in‐vitro to particles and lipopolysaccharide. Unpublished data
13. 13 Dong W, Lewtas J, Luster MI: Role of endotoxin in tumor necrosis factor alpha expression from alveolar macrophages treated with urban air particles. Exp Lung Res 22: 577–592, 1996
14. 14 Friedman RJ, Black J, Galante JO, Jacobs JJ, Skinner HB: Current concepts in orthopaedic biomaterials and implant fixation. J Bone Joint Surg [Am] 75: 1086–1109, 1993
15. 15 Geng Y, Zhang B, Lotz M: Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 151: 6692–6700, 1993
16. 16 Glant TT, Jacobs JJ: Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures. J Orthop Res 12: 720–731, 1994
17. 17 Glant TT, Dobai JG, Ramesh N, Chandrasekaran R, Carpenter L, Galante JO, Roebuck K: Phagocytosis of titanium particulates activates protein tyrosine kinase pathway and transcription factor NF‐κB, upregulates. IL‐6 production and suppresses collagen synthesis in osteoblasts. Trans Orthop Res Soc 24: 246, 1999
18. 18 Gonzales JB, Purdon MA, Horowitz SM: In vitro studies on the role of titanium in aseptic loosening. Clin Orthop 330: 244–250, 1996
19. 19 Harada Y, Brown S, Merritt K, Wang JT, Doppalapudi VA, Willis AA, Jasty M, Harris WH, Goldring SR: Effects of metal particles and their corrosion products on human monocyte/macrophages in vitro. Trans Orthop Res Soc 20: 776, 1995
20. 20 Harada Y, Wang JT, Doppalapudi VA, Willis AA, Jasty M, Harris WH, Nagase M, Goldring SR: Differential effects of different forms of hydroxyapatite and hydroxyapatite/tricalcium phosphate particulates on human monocytes/macrophages in vitro. J Biomed Mater Res 31: 19–26, 1996
21. 21 Hasselman CT, Kovach CJ, Keys B, Rubash HE, Shanbhag AS: Macrophage response to synergistic challenge with prosthetic wear debris. Trans Orthop Res Soc 22: 739, 1997
22. 22 Haynes DR, Rogers SD, Hay S, Pearcy MJ, Howie DW: The differences in toxicity and release of bone‐resorbing mediators induced by titanium and cobalt‐chromium‐alloy wear particles. J Bone Joint Surg [Am] 75: 825–834, 1993
23. 23 Hicks DG, Judkins AR, Sickel JZ, Rosier RN, Puzas JE, O'Keefe RJ: Granular histiocytosis of pelvic lymph nodes following total hip arthroplasty: the presence of wear debris, cytokine production, and immunologically activated macrophages. J Bone Joint Surg [Am] 78: 482–496, 1996
24. 24 Hitchins VM, Merritt K: Decontaminating particles exposed to bacterial endotoxin (LPS). J Biomed Mater Res 46: 434–437, 1999
25. 25 Horowitz MC, Jilka RL, Einhorn TA: Effect of endotoxin (lipopolysaccharide) on bone cell function, bone allograft incorporation, and fracture repair. In: Musculoskeletal Infection, pp 271–289. Ed by JL Esterhai Jr, AG Gristina, and R Poss. Park Ridge, Illinois, American Academy of Orthopaedic Surgeons, 1992
26. 26 Howie DW, Haynes DR, Rogers SD, McGee MA, Pearcy MJ: The response to particulate debris. Orthop Clin North Am 24: 571–581, 1993
27. 27 Jagielo PJ, Thorne PS, Kern JA, Quinn TJ, Schwartz DA: Role of endotoxin in grain dust‐induced lung inflammation in mice. Am J Physiol 270: L1052–L1059, 1996
28. 28 Kane KR, Mochel DM, Deheer DH, Beebe JD, Marks TR, Hamstra DJ, Swanson AB: Influence of titanium particle size on the in vitro activation of macrophages. Contemp Orthop 28: 249–261, 1994
29. 29 Katakami Y, Nakao Y, Koizumi T, Katakami N, Ogawa R, Fujita T: Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP. Immunology 64: 719–724, 1988
30. 30 Kim KJ, Hashimoto J, Morita H, Sato K, Kashiwazaki S: Effects of implant particles on the production of IL‐1 and IL‐6 by bone marrow cells. Trans Orthop Res Soc 17: 341, 1992
31. 31 Lee S‐H, Brennan FR, Jacobs JJ, Urban RM, Ragasa DR, Glant TT: Human monocyte/macrophage response to cobaltchromium corrosion products and titanium particles in patients with total joint replacements. J Orthop Res 15: 40–49, 1997
32. 32 Majde JA: Endotoxin detection [letter]. Immunol Today 13: 328–329, 1992
33. 33 Merkel KD, Erdmann JM, McHugh K, Abu‐Amer Y, Ross FP, Teitelbaum SL: Tumor necrosis factor‐α mediates orthopedic implant osteolysis. Am J Pathol 154: 203–210, 1999
34. 34 Miller KM, Anderson JM: Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. J Biomed Mater Res 22: 713–731, 1988
35. 35 Nakashima Y, Sun DH, Trindade MC, Maloney WJ, Goodman SB, Schurman DJ, Smith RL: Signaling pathways for tumor necrosis factor‐α and interleukin‐6 expression in human macrophages exposed to titanium‐alloy particulate debris in vitro. J Bone Joint Surg [Am] 81: 603–615, 1999
36. 36 Nelson SK, Knoernschild KL, Robinson FG, Schuster GS: Lipopolysaccharide affinity for titanium implant biomaterials. J Prosthet Dent 77: 76–82, 1997
37. 37 Niwa M, Milner KC, Ribi E, Rudbach JA: Alteration of physical, chemical, and biological properties of endotoxin by treatment with mild alkali. J Bacteriol 97: 1069–1077, 1969
38. 38 Novitsky TJ, Schmidt‐Gengenbach J, Remillard JF: Factors affecting recovery of endotoxin adsorbed to container surfaces. J Parenter Sci Technol 40: 284–286, 1986
39. 39 Pacifici R, Carano A, Santoro SA, Rifas L, Jeffrey JJ, Malone JD, McCracken R, Avioli LV: Bone matrix constituents stimulate interleukin‐1 release from human blood mononuclear cells. J Clin Invest 87: 221–228, 1991
40. 40 Ragab AA, Bi Y, Lavish SA, Van de motter RR, Goldberg VM, Greenfield EM: Stimulation of cytokine production by titanium wear particles is due to adherent endotoxin. Trans Orthop Res Soc 23: 355, 1998
41. 41 Ritchie CK, Johnson R, Farrell ED, Horowitz SM: Effect of protein kinase C modulators on particle‐induced tumor necrosis factor alpha production. Trans Orthop Res Soc 23: 123, 1998
42. 42 Ryan LK, Vermeulen MW: Alveolar macrophages from C3H/HeJ mice show sensitivity to endotoxin. Am J Respir Cell Mol Biol 12: 540–546, 1995
43. 43 Schwartz DA, Thorne PS, Yagla SJ, Burmeister LF, Olenchock SA, Watt JL, Quinn TJ: The role of endotoxin in grain dustinduced lung disease. Am J Respir Crit Care Med 152: 603–608, 1995
44. 44 Schwarz E, Bukata S, Benz E, Rosier RN, Puzas JE, O'Keefe RJ: NFKB and TNF‐alpha are stimulated by titanium particles and are essential for in vivo bone resorption. Trans Orthop Res Soc 24: 305, 1999
45. 45 Shanbhag AS, Jacobs JJ, Black J, Galante JO, Glant TT: Human monocyte response to particulate biomaterials generated in vivo and in vitro. J Orthop Res 13: 792–801, 1995
46. 46 Shanbhag AS, Macaulay W, Stefanovic‐Racic M, Rubash HE: Nitric oxide release by macrophages in response to particulate wear debris. J Biomed Mater Res 41: 497–503, 1998
47. 47 Sweet MJ, Hume DA: Endotoxin signal transduction in macrophages. J Leukoc Biol 60: 8–26, 1996
48. 48 Theiss SM, Luchetti W, Baker DG, Cuckler JM: The effect of endotoxin on the inflammatory response to particulate debris. Trans Orthop Res Soc 18: 269, 1993
49. 49 Vallance P, Moncada S: Role of endogenous nitric oxide in septic shock. New Horiz 1: 77–86, 1993
50. 50 Van Arman CG, Carlson RP, Kling PJ, Allen DJ, Bondi JV: Experimental gouty synovitis caused by bacterial endotoxin adsorbed onto urate crystals. Arthitis Rheum 17: 439–449, 1974
51. 51 Weinberg JB: Endotoxin contamination and in vitro monocyte‐macrophage function: methods of detecting, detoxifying, and eliminating endotoxin. In: Methods for Studying Mononuclear Phagocytes, pp 139–154, Ed by DO Adams, PJ Edelson, and HS Koren. New York, Academic Press, 1981
52. 52 Williams PB, Halsey JF: Endotoxin as a factor in adverse reactions to latex gloves. Ann Allergy Asthma Immunol 79: 303–310, 1997
53. 53 Wright TM, Goodman SB [eds]: Implant Wear: The Future of Total Joint Replacement. Rosemont, Illinois, American Academy of Orthopaedic Surgeons, 1996
54. 54 Yamamoto K, Noishiki Y, Mo M, Kondo J, Matsumoto A: Unusual inflammatory responses around a collagen‐impregnated vascular prosthesis. Artif Organs 17: 1010–1016, 1993
55. 55 Zablotsky MH, Wittrig EE, Diedrich DL, Layman DL, Meffert RM: Fibroblastic growth and attachment on hydroxyapatite‐coated titanium surfaces following the use of various detoxification modalities. Part II. Contaminated hydroxyapatite. Implant Dent 1: 195–202, 1992